Frontiers in Oncology (Jan 2022)

Case Report: Recurrence of Testicular Myofibroblastic Tumor After Surgery

  • Jiayi Liu,
  • Jiayi Liu,
  • Zhijie Bai,
  • Shuaiqi Li,
  • Sheng Zeng,
  • Chuang Li,
  • Qian Liu

DOI
https://doi.org/10.3389/fonc.2021.810708
Journal volume & issue
Vol. 11

Abstract

Read online

Inflammatory myofibroblastic tumour (IMT), also known as plasma cell granuloma (PCG) or inflammatory pseudotumour (IPT), is a distinctive, rarely metastasizing neoplasm composed of myofibroblastic and fibroblastic spindle cells accompanied by inflammatory infiltration of plasma cells, lymphocytes and/or eosinophils. IMT predominantly affects children and young adults, and the age at presentation ranges from 3 to 89 years. We present a very rare case of recurrent testicular IMT without ALK rearrangement. This case highlights the clinical characteristics and diagnostic factors associated with primary and recurrent foci of this rare tumour, along with key therapeutic approaches.

Keywords